Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 195

1.

Acetylsalicylic acid (ASA) - How much, how often, and when? A clinical-pharmacological perspective.

Loew D, Belz GG.

Int J Clin Pharmacol Ther. 2016 Aug;54(8):634-9. doi: 10.5414/CP202539.

PMID:
27125773
2.

[Moderate wine consumption and prevention of coronary heart disease].

Worm N, Belz GG, Stein-Hammer C.

Dtsch Med Wochenschr. 2013 Dec;138(51-52):2653-7. doi: 10.1055/s-0033-1359900. Epub 2013 Dec 16. German.

PMID:
24343181
3.

[Vitamin D for prevention of diseases?].

Eichhorn A, Lochner S, Belz GG.

Dtsch Med Wochenschr. 2012 Apr;137(17):906-12. doi: 10.1055/s-0032-1304910. Epub 2012 Apr 10. Review. German. Erratum in: Dtsch Med Wochenschr. 2012 Jun;137(24):1283.

PMID:
22492477
4.

[Cacoa and dark chocolate in cardiovascular prevention?].

Belz GG, Mohr-Kahaly S.

Dtsch Med Wochenschr. 2011 Dec;136(51-52):2657-63. doi: 10.1055/s-0031-1292826. Epub 2011 Dec 14. Review. German.

PMID:
22169919
5.

[Comment on M. Lambeck: Quantum physics, medicine and insurance]].

Belz GG.

Versicherungsmedizin. 2008 Jun 1;60(2):90. German. No abstract available.

PMID:
18595648
8.
9.

The pharmacological potency of various AT(1) antagonists assessed by Schild regression technique in man.

Belz GG, Breithaupt-Grögler K, Butzer R, Fuchs W, Hausdorf C, Mang C.

J Renin Angiotensin Aldosterone Syst. 2000 Dec;1(4):336-41.

PMID:
11967820
10.
11.

Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.

Breithaupt-Grögler K, Ungethüm W, Meurer-Witt B, Belz GG.

Eur J Clin Pharmacol. 2001 Jul;57(4):275-84.

PMID:
11549204
12.

Treatment of congestive heart failure--current status of use of digitoxin.

Belz GG, Breithaupt-Grögler K, Osowski U.

Eur J Clin Invest. 2001;31 Suppl 2:10-7. Review.

PMID:
11525233
13.

Pharmacological differences among angiotensin II receptor antagonists.

Belz GG.

Blood Press Suppl. 2001;2:13-8. Review.

PMID:
11465912
14.

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo-controlled, double-blind study.

Grötz KA, Wüstenberg P, Kohnen R, Al-Nawas B, Henneicke-von Zepelin HH, Bockisch A, Kutzner J, Naser-Hijazi B, Belz GG, Wagner W.

Br J Oral Maxillofac Surg. 2001 Feb;39(1):34-9.

PMID:
11178853
15.

Blocking the tissue renin-angiotensin system: the future cornerstone of therapy.

Unger T, Azizi M, Belz GG.

J Hum Hypertens. 2000 Oct;14 Suppl 2:S23-31. Review.

16.

Comparative pharmacodynamics and pharmacokinetics of candesartan and losartan in man.

Fuchs B, Breithaupt-Grögler K, Belz GG, Roll S, Malerczyk C, Herrmann V, Spahn-Langguth H, Mutschler E.

J Pharm Pharmacol. 2000 Sep;52(9):1075-83.

PMID:
11045887
17.
18.

[Prospective double-blind study of prophylaxis of radioxerostomia with Coumarin/Troxerutine in patients with head and neck cancer].

Grötz KA, Henneicke-von Zepelin HH, Kohnen R, al-Nawas B, Bockisch A, Kutzner J, Wüstenberg P, Naser-Hijazi B, Belz GG, Wagner W.

Strahlenther Onkol. 1999 Aug;175(8):397-403; discussion 404. German.

PMID:
10481772
19.

Epidemiology of the arterial stiffness.

Breithaupt-Grögler K, Belz GG.

Pathol Biol (Paris). 1999 Jun;47(6):604-13. Review.

PMID:
10472071
20.

Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data.

Breithaupt-Grögler K, Niebch G, Schneider E, Erb K, Hermann R, Blume HH, Schug BS, Belz GG.

Eur J Pharm Sci. 1999 Apr;8(1):57-65.

PMID:
10072479

Supplemental Content

Loading ...
Support Center